Pharmidex partners with Data Sciences International (DSI) to utilise industry-leading whole body plethysmography (WBP) systems, incorporating the patented Halcyon® pneumotach noise suppression technology.
This enables the delivery of high-quality preclinical respiratory studies with enhanced clarity, sensitivity and confidence.
By leveraging the robustness of DSI’s WBP platform alongside Pharmidex’s scientific expertise, we offer well-characterised models to assess:
• Cough responses
• Hypercapnic challenge responses
• Functional respiratory changes across disease states such as asthma
This integrated approach supports reliable and translatable assessment of airway function, disease progression and therapeutic efficacy, helping to de-risk programmes and drive better decision-making in preclinical development.
Always keen to hear how others are advancing respiratory endpoints in their studies.
